Latest Breaking News On - Canale communications - Page 10 : comparemela.com

MEI Pharma Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)

SAN DIEGO (BUSINESS WIRE) MEI Pharma, Inc. (NASDAQ: MEIP), a late-stage pharmaceutical company focused on advancing new therapies for cancer, today announced the grant of inducement stock options for an aggregate of 65,000 shares of the company’s common stock to two new employees. The stock options were granted as.

Davida walseyDrug administrationCanale communicationsPharma incNasdaq listing ruleGrant equity compensation planOmnibus equity compensationCompensation committeePrivate securities litigation reform act

MEI Pharma Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)

MEI Pharma Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Davida walseyDrug administrationCanale communicationsPharma incWall streetNasdaq listing ruleGrant equity compensation planOmnibus equity compensationCompensation committeePrivate securities litigation reform act

Taysha Gene Therapies Announces Annual Stockholder Meeting

The Annual Stockholder Meeting on Friday, June 17, 2022 at 10 am ET.

United statesKimberly leeCarolyn hawleyTaysha gene therapies incCompany contactCanale communicationsCorporate affairsUt southwestern gene therapy programGene therapiesTaysha corporateGene therapy programNasdaq tshaTaysha gene therapies

eFFECTOR Therapeutics Reports Positive Interim Results in Zotatifin (eFT226) Phase 1/2 Clinical Trial at ASCO 2022 Showing Safety and Tolerability, and Initial Signals of Clinical Activity - Press Release

Two partial responses observed in heavily pre-treated ER+ breast cancer patientsOne ongoing cohort in ER+ breast cancer has been expanded and new expa

United statesSan franciscoStephanie carringtonSteve worlandNellieb connallyHeidi chokeirUniversity of californiaEffector therapeutics incUniversity of texas md anderson cancer centerCanale communicationsExchange commissionInternational dialDefense advanced research projects agencyFunda meric bernstamInvestigational cancer therapeuticsBreast cancer

eFFECTOR Therapeutics Reports Positive Interim Results in Zotatifin (eFT226) Phase 1/2 Clinical Trial at ASCO 2022 Showing Safety and Tolerability, and Initial Signals of Clinical Activity

eFFECTOR Therapeutics Reports Positive Interim Results in Zotatifin (eFT226) Phase 1/2 Clinical Trial at ASCO 2022 Showing Safety and Tolerability, and Initial Signals of Clinical Activity
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesSan franciscoSteve worlandNellieb connallyHeidi chokeirStephanie carringtonicr westwickeUniversity of californiaEffector therapeutics incUniversity of texas md anderson cancer centerExchange commissionInternational dialDefense advanced research projects agencyPh dcanale communicationsWall streetFunda meric bernstamInvestigational cancer therapeutics